Creative Disruption Forum on Neuroscience Innovations for Degenerative Diseases

Our Creative Disruption Forums are moderated by esteemed industry leader Prof Tony Sedgwick. It is an interview-led discussion forum led by business and research leaders which start with various keynote interviews, and then after lunch, an opportunity to join smaller discussion workshops. It is designed to help share information on business, research and strategy plus build business relationships whilst debating important topics. This edition focuses on the business and strategy of Neuroscience Innovation for Degenerative Diseases. If this is an area of interest for you, or you are simply curious, we would like it if you can join us.

Do you want to hear what sector’s most influential thinkers say about strategies for neuroscience treatements and innovations for neurodegenarative diseases, and what the future holds for this field. Here is a taste of the likely topics to be discussed in our unique discussion format with keynote interviews with leaders in the field moderated by our forever curious thought-leader Prof Tony Sedgwick. Here are likely some of the areas we will cover.

1. Strategic Landscape

2. Gene-Therapy & Gene-Editing Advances

3. Stem-Cell & Regenerative Strategies

4. Neuroprosthetics & Brain-Computer Interfaces (BCI)

5. Pharmaceutical Pipeline and where are the opportunities, and what's been invested in.

6. Cross-Cutting Enablers: AI & Computational Biology

7. Global Collaboration, Access & Policy

8. Anticipated Impact on Patient Care

9. Challenges Ahead

10. What's the 10-year Outlook

 

Chatham House Rules apply - "what goes on in the Forum, stays in the Forum - so to speak!"

Who should attend

The #CreativeDisruption Forum is designed for professionals working in life sciences who are driving innovation and growth. It is ideal for:

  • Founders and executives of biotech, medtech, and healthtech companies
  • R&D and clinical development leaders
  • Investors and business strategists in the healthcare sector
  • Innovation managers, consultants, and academic partners involved in commercialisation
  • Students and early-career researchers interested in understanding how scientific innovation translates into successful business ventures